ACIP, CDC, and Insurance Coverage of Vaccines in the United States
This brief provides an overview of vaccine coverage requirements by payer or program, as they relate to ACIP and the CDC.
View the Latest: Food and Drug Administration (FDA)
Filter
-
-
Federal Vaccine Advisory Committees: Roles and Current Issues
Issue BriefThis brief describes four key federal vaccine advisory committees and discusses policy issues and questions they currently face. The four committees are the Vaccines and Related Biological Products Advisory Committee (VRBPAC) at the Food and Drug Administration (FDA); the Advisory Committee on Immunization Practices (ACIP) at the Centers for Disease Control and Prevention (CDC); the National Vaccine Advisory Committee (NVAC) at the Department of Health and Human Services (HHS); and the Advisory Commission on Childhood…
-
How Could FDA’s New Guidance Affect COVID-19 Vaccination Coverage in the U.S.?
Quick InsightsTaken together, the new guidance on clinical trial requirements, the more restricted approval of the Novavax vaccine, and anticipated changes to CDC recommendations add up to fewer Americans eligible for COVID-19 vaccines and more limited access to these vaccines compared to previous years...such a shift would place the U.S. more in line with Australia, Canada, and countries in Europe.
-
Skepticism Surrounding ADHD Diagnoses and Medication — The Monitor
FeatureThis volume examines the impact of recent executive actions on federal health communication, along with concerns and stigmas surrounding ADHD diagnoses and treatments, including skepticism about pharmaceutical influence on medication promotion. It also explores distrust in food regulations following the FDA’s ban on Red Dye No. 3.
-
Distrust in Food Safety and Social Media Content Moderation — The Monitor
FeatureThis volume addresses rising distrust in food safety, shifts in social media content moderation, and the trend of self-diagnosis and treatment based on social media videos.
-
The Supreme Court, Medication Abortion, and the FDA: What’s at Stake?
News ReleaseIn advance of oral arguments about access to medication abortion before the Supreme Court on March 26, KFF examines how a Court ruling for the plaintiffs would limit access to mifepristone blocking its use in telehealth and distribution through pharmacies, including in states where abortion is legal and protected. In addition, it could potentially weaken the role of the Food and Drug Administration (FDA) in drug reviews—something the Court has never done before. As part…
-
What’s at Stake for Access to Medication Abortion and the FDA in the Supreme Court Case FDA v. the Alliance for Hippocratic Medicine?
Issue BriefThe Supreme Court will be hearing oral arguments for the case FDA v. Alliance for Hippocratic Medicine. This brief explains the issues at stake before the court and their implications for the drug regulatory process and medication abortion access throughout the country.
-
KFF Health News and CBS News Win 2023 George Polk Award for Medical Reporting
News ReleaseKFF Health News won the 2023 George Polk Award for Medical Journalism for its year-long investigation with CBS News into the failure of FDA-approved medical devices that were suspected of contributing to thousands of injuries and patient deaths. The George Polk Awards were established in 1949 by Long Island University to commemorate George Polk, a CBS correspondent murdered in 1948 while covering the Greek Civil War. The awards place a premium on investigative and enterprising…